Clinical Trial Update: Study to Evaluate the Efficacy of Lactobacillus Crispatus M247 in the Prevention and Treatment of Recurrent Urinary Tract Infections [NA]

View source ↗

Summary

A completed clinical trial evaluating Lactobacillus crispatus M247 for prevention and treatment of recurrent urinary tract infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urinary Tract Infection

Drugs mentioned

• Lactobacillus crispatus M247

Snippet

Sponsor: Liaquat University of Medical & Health Sciences | Conditions: Recurrent Urinary Tract Infection | NA | Status: COMPLETED